A US study of more than a million Medicaid enrollees newly diagnosed with opioid use disorder (OUD), finds most—nearly seven ...

We can’t solve what we can’t measure, so let’s use opioid abatement funds to help. Comprehensive toxicology would let us ...

America’s overdose crisis isn’t the simple story we’ve been told for years. A new investigation reveals how two key graphs — ...

A class of synthetic drugs called nitazines have been around since the 1950s - but are quickly gaining a foothold in street ...

Nitazene was first developed in the 1950s as an analgesic, but was never approved for medical use. Instead, it was “limited to those researching opioid pharmacology,” said Rolling Stone. Nitazene’s ...

Opioids are still widely prescribed, but have limited effectiveness and are associated with serious harms. De-prescribing ...

For patients recovering from opioid use disorder, particularly from drugs like fentanyl or heroin, the days immediately following a hospital stay are among the most dangerous. A new multi-state study ...

A new opioid-free pain medication was approved by the U.S. Food and Drug Administration (FDA) on Thursday, marking a non-addictive alternative for patients. Journavx (suzetrigine), made by Vertex, is ...

Illicit drugs aren’t tested by the FDA or pure, nor as advertised by drug dealers. Illegal drugs are cartel-driven around profit maximization, cash-only trading, and a form of entrepreneurship.

A new study led by researchers at the University of Toronto's Leslie Dan Faculty of Pharmacy and Unity Health Toronto shows ...

The U.S. Food and Drug Administration (FDA) has approved a new drug for the treatment of moderate-to-severe pain that is a non-opioid and carries less risks of addiction than opioids. Journavx works ...

The arrest comes after accusations by several women that he withheld critical resources in exchange for sexual acts.